These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 858083
1. Characterization of an activating factor required for hydrolysis of Gm2 ganglioside catalyzed by hexosaminidase A. Hechtman P. Can J Biochem; 1977 Apr; 55(4):315-24. PubMed ID: 858083 [Abstract] [Full Text] [Related]
2. Purification and properties of the hexosaminidase A-activating protein from human liver. Hechtman P, LeBlanc D. Biochem J; 1977 Dec 01; 167(3):693-701. PubMed ID: 603630 [Abstract] [Full Text] [Related]
7. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB. Hechtman P, Gordon BA, Ng Ying Kin NM. Pediatr Res; 1982 Mar 01; 16(3):217-22. PubMed ID: 6801612 [Abstract] [Full Text] [Related]
11. The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis. Hirabayashi Y, Li YT, Li SC. J Neurochem; 1983 Jan 01; 40(1):168-75. PubMed ID: 6848657 [Abstract] [Full Text] [Related]
12. Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A. Conzelmann E, Sandhoff K. Hoppe Seylers Z Physiol Chem; 1979 Dec 01; 360(12):1837-49. PubMed ID: 527942 [Abstract] [Full Text] [Related]
13. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses. Harzer K. Clin Chim Acta; 1983 Nov 30; 135(1):89-93. PubMed ID: 6228344 [No Abstract] [Full Text] [Related]
14. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2. Conzelmann E, Burg J, Stephan G, Sandhoff K. Eur J Biochem; 1982 Apr 01; 123(2):455-64. PubMed ID: 6210531 [Abstract] [Full Text] [Related]
15. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures. Raghavan SS, Krusell A, Krusell J, Lyerla TA, Kolodny EH. Am J Hum Genet; 1985 Nov 01; 37(6):1071-82. PubMed ID: 2934978 [Abstract] [Full Text] [Related]
16. Hydrolysis of Tay-Sachs ganglioside by beta-hexosaminidase A of human liver and urine. Li YT, Mazzotta MY, Wan CC, Orth R, Li SC. J Biol Chem; 1973 Nov 10; 248(21):7512-5. PubMed ID: 4745777 [No Abstract] [Full Text] [Related]
17. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein. Inui K, Grebner EE, Jackson LG, Wenger DA. Am J Hum Genet; 1983 Jul 10; 35(4):551-64. PubMed ID: 6224417 [Abstract] [Full Text] [Related]
18. Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D precursor in vitro and activity of beta-hexosaminidase A precursor towards ganglioside GM2. Hasilik A, von Figura K, Conzelmann E, Nehrkorn H, Sandhoff K. Eur J Biochem; 1982 Jul 10; 125(2):317-21. PubMed ID: 6214395 [Abstract] [Full Text] [Related]
19. Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis. Erzberger A, Conzelmann E, Sandhoff K. Clin Chim Acta; 1980 Dec 22; 108(3):361-8. PubMed ID: 6781795 [Abstract] [Full Text] [Related]
20. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate. Poulos A, Holding J, Carey WF. Clin Chim Acta; 1982 Apr 23; 120(3):331-40. PubMed ID: 6210469 [Abstract] [Full Text] [Related] Page: [Next] [New Search]